TY  - RPRT
TI  - Risk-Benefit of Phase 2 Monotherapy Trials in Adult Solid Cancers: A Systematic Review and Meta-Analysis.
AU  - Charlotte Ouimet
AU  - Monica Rosu
AU  - Jonathan Kimmelman
PY  - 2026
DO  - 10.1002/ijc.70538
UR  - https://pubmed.ncbi.nlm.nih.gov/42117884/
ID  - 42117884
ER  -